Bioptik TechnologyROCO:4161 68 Gross Margin % is 30.16% as of Dec. 2025, which is 19% above its 10-year median of 25.28. GuruFocus rates ROCO:4161 with a GF Score™ of 68/100 and a GF Value™ of NT$27.79 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 807 Medical Devices & Instruments companies, Bioptik Technology ranks worse than 82.65% on this metric.
The historical rank and industry rank for Bioptik Technology's Gross Margin % or its related term are showing as below:
ROCO:4161'
s Gross Margin % Range Over the Past 10 Years
Min: 17.12 Med: 25.28 Max: 30.96
Current: 29.09
During the past 13 years, the highestGross Margin % of Bioptik Technology was 30.96%. The lowest was 17.12%. And the median was 25.28%.
ROCO:4161's Gross Margin % is ranked worse than 82.65% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs ROCO:4161: 29.09
Bioptik Technology had a gross margin of 30.16% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Bioptik Technology was 11.70% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bioptik Technology had a gross margin of 30.16% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bioptik Technology Gross Margin % Related Terms
Bioptik Technology Gross Margin % Historical Data
* Premium members only.
The historical data trend for Bioptik Technology's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4161 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Bioptik Technology's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioptik Technology Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioptik Technology's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bioptik Technology's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bioptik Technology (ROCO:4161) has a Gross Margin % of 30.16% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Bioptik Technology and its competitors. This is 19% above median its historical median of 25.28. Over the past decade, Bioptik Technology's Gross Margin % has ranged from 17.12 to 30.96. According to the industry distribution chart, Bioptik Technology ranks #667 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 82.7%.
Is Bioptik Technology's Gross Margin % too high?
Bioptik Technology's current Gross Margin % of 30.16% is 19% above median its 10-year median of 25.28. Over the past 10 years, this metric has ranged from a low of 17.12 to a high of 30.96. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Bioptik Technology's value of 30.16% is 42% below this industry median. Based on the distribution chart, Bioptik Technology ranks #667 out of 807 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bioptik Technology has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioptik Technology's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bioptik Technology ranks #667 out of 807 companies for Gross Margin %. This places Bioptik Technology in the lower half of its industry. The industry median Gross Margin % is 52.03. Bioptik Technology's value of 30.16% is 42% below this benchmark. Historically, Bioptik Technology's own Gross Margin % has ranged from 17.12 to 30.96 over the past decade. While the company's 10-year median is 25.28 vs. the industry median of 52.03, Bioptik Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioptik Technology's current Gross Margin % of 30.16% is 42% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Bioptik Technology and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioptik Technology's current Gross Margin % is 30.16%, which is 19% above median its own 10-year median of 25.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioptik Technology stock overvalued right now?
Based on GuruFocus' analysis, Bioptik Technology (ROCO:4161) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$27.79, compared to a current price of NT$23.00 — trading 17.2% below its estimated fair value. The current Gross Margin % is 30.16%, which is 19% above median its 10-year median of 25.28 and 42% below the Medical Devices & Instruments industry median of 52.03. Bioptik Technology's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Bioptik Technology (ROCO:4161), the current Gross Margin % is 30.16% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioptik Technology (ROCO:4161) Overvalued in 2026?
Based on GuruFocus' analysis, Bioptik Technology stock appears to be undervalued.
The current stock price of NT$23.00 is trading 17.2% below its estimated GF Value™ of NT$27.79.
GuruFocus considers Bioptik Technology to be Modestly Undervalued.
Key valuation signals for ROCO:4161:
Gross Margin %: 30.16% (19% above median its 10-year median of 25.28)
GF Value™: NT$27.79 vs. price of NT$23.00 (17.2% below fair value)
Industry Position: 42% below the Medical Devices & Instruments median (#667 of 807)
No single metric tells the full story. See the ROCO:4161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.
68GF Score
Get the complete analysis for ROCO:4161
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4161 has been successfully added to your 
